Calendar Intensity Therapeutics, Inc.

Equities

INTS

US45828J1034

Market Closed - Nasdaq 21:00:00 21/06/2024 BST 5-day change 1st Jan Change
4.85 USD +3.85% Intraday chart for Intensity Therapeutics, Inc. -0.41% -43.41%

Chart calendar Intensity Therapeutics, Inc.

384706235b35e1efb1b4.k_hlN-8W6H6y4JE4FeOhbKpsJQcfMezAVGyym1GNcwo.9a9cR65OiizHttpoVpHbFMhaem8uCJWXNxjx4wm4LFrkoCBjlnzdBN7R9g~f23f08996ce8c861e644f2e990536b28

Upcoming events on Intensity Therapeutics, Inc.

17/07/2024 15:30 Annual General Meeting
11/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
12/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Intensity Therapeutics, Inc.

09/05/2024 21:08 Q1 2024 Earnings Release
09/04/2024 20:30 LD Micro Invitational Conference
19/03/2024 19:30 Roth Conference
14/03/2024 20:09 Q4 2023 Earnings Release
26/02/2024 16:45 BIO CEO & Investor Conference
08/12/2023 13:00 San Antonio Breast Cancer Symposium - PS16-03
13/11/2023 13:01 Q3 2023 Earnings Release
31/10/2023 Connective Tissue Oncology Society Meeting - Abstract Number: 1574238
04/10/2023 20:30 LD Micro Main Conference
11/09/2023 21:30 H.C. Wainwright Global Investment Conference
14/08/2023 13:00 Q2 2023 Earnings Call
14/08/2023 12:01 Q2 2023 Earnings Release
08/12/2022 13:00 San Antonio Breast Cancer Symposium - Poster Number : PD11-02
18/11/2022 23:30 Connective Tissue Oncology Society Meeting - Abstract No: 1301741
11/11/2022 14:00 Society for Immunotherapy of Cancer Meeting - Abstract Number: 710
10/11/2022 14:00 Society for Immunotherapy of Cancer Meeting - Abstract No: 545

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-8,32
-7,52
-10.68%

-19,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-10,5
-11,1
5.07%

-19,3

Net income
Million USD
Released
Forecast
Spread
-7,58


-11,9
-11,1
-6.86%

-19,3

EPS
USD
Released
Forecast
Spread
-2,22


-1,38
-2,32
40.52%

-1,40

Announcement Date18/05/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-1,22
-1,30
6.02%
-2,49
-1,50
-66.03%
-3,35
-2,55
-31.48%




-4,80


-5,00


-5,20

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,70
-1,38
-167.96%
-2,33
-1,26
-84.9%
-3,17
-2,41
-31.59%




-4,68


-4,90


-5,12

Net income
Million USD
Released
Forecast
Spread
-3,70
-1,38
-167.96%
-2,33
-1,26
-84.9%
-4,50
-2,41
-86.52%




-4,68


-4,90


-5,12

EPS
USD
Released
Forecast
Spread
-1,05
-0,40
-162.5%
-0,17
-0,09
-88.89%
-0,12
-0,18
33.33%
-0,34
0,00
-

-0,34


-0,36


-0,37

Announcement Date14/08/2313/11/2314/03/2409/05/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. INTS Stock
  4. Calendar Intensity Therapeutics, Inc.